Short Interest in CSL Limited (OTCMKTS:CSLLY) Decreases By 62.5%

CSL Limited (OTCMKTS:CSLLY) was the target of a significant decrease in short interest in the month of November. As of November 30th, there was short interest totalling 600 shares, a decrease of 62.5% from the November 15th total of 1,600 shares. Based on an average daily volume of 307,600 shares, the days-to-cover ratio is presently 0.0 days.

CSL Stock Down 0.5 %

OTCMKTS:CSLLY traded down $0.48 during mid-day trading on Wednesday, reaching $89.44. The stock had a trading volume of 24,925 shares, compared to its average volume of 35,915. CSL has a 12 month low of $85.70 and a 12 month high of $109.00. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.97 and a current ratio of 2.18. The stock has a 50-day simple moving average of $94.55 and a two-hundred day simple moving average of $98.04.

Wall Street Analyst Weigh In

Separately, Macquarie raised shares of CSL to a “strong-buy” rating in a report on Tuesday, August 13th.

About CSL

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.